These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1531387)

  • 41. Serotonergic component of SCH 23390: in vitro and in vivo binding analyses.
    McQuade RD; Ford D; Duffy RA; Chipkin RE; Iorio LC; Barnett A
    Life Sci; 1988; 43(23):1861-9. PubMed ID: 2904635
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dopamine D1 binding sites in the striatum of the mutant mouse weaver.
    Ohta K; Graybiel AM; Roffler-Tarlov S
    Neuroscience; 1989; 28(1):69-82. PubMed ID: 2527338
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Measurement of cortical dopamine d1 receptor binding with 11C[SCH23390]: a test-retest analysis.
    Hirvonen J; Någren K; Kajander J; Hietala J
    J Cereb Blood Flow Metab; 2001 Oct; 21(10):1146-50. PubMed ID: 11598491
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of cerebral ischemia on dopamine receptors in the gerbil striatum.
    Araki T; Kato H; Shuto K; Fujiwara T; Kogure K; Itoyama Y
    Eur J Pharmacol; 1996 Jun; 306(1-3):73-9. PubMed ID: 8813617
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acute amphetamine down-regulates RGS4 mRNA and protein expression in rat forebrain: distinct roles of D1 and D2 dopamine receptors.
    Schwendt M; Gold SJ; McGinty JF
    J Neurochem; 2006 Mar; 96(6):1606-15. PubMed ID: 16539683
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Guanine nucleotide regulation of agonist interactions at [3H]SCH23390-labeled D1 dopamine receptors in rat striatum.
    Hess EJ; Battaglia G; Norman AB; Iorio LC; Creese I
    Eur J Pharmacol; 1986 Feb; 121(1):31-8. PubMed ID: 2869957
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantification of neuroreceptors in the living human brain: IV. Effect of aging and elevations of D2-like receptors in schizophrenia and bipolar illness.
    Wong DF; Pearlson GD; Tune LE; Young LT; Meltzer CC; Dannals RF; Ravert HT; Reith J; Kuhar MJ; Gjedde A
    J Cereb Blood Flow Metab; 1997 Mar; 17(3):331-42. PubMed ID: 9119906
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vivo imaging of baboon and human dopamine transporters by positron emission tomography using [11C]WIN 35,428.
    Wong DF; Yung B; Dannals RF; Shaya EK; Ravert HT; Chen CA; Chan B; Folio T; Scheffel U; Ricaurte GA
    Synapse; 1993 Oct; 15(2):130-42. PubMed ID: 8259524
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: compartment analysis for beta-CFT binding with positron emission tomography.
    Ouchi Y; Yoshikawa E; Okada H; Futatsubashi M; Sekine Y; Iyo M; Sakamoto M
    Ann Neurol; 1999 May; 45(5):601-10. PubMed ID: 10319882
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Distribution of messenger RNAs for D1 dopamine receptors and DARPP-32 in striatum and cerebral cortex of the cynomolgus monkey: relationship to D1 dopamine receptors.
    Brené S; Hall H; Lindefors N; Karlsson P; Halldin C; Sedvall G
    Neuroscience; 1995 Jul; 67(1):37-48. PubMed ID: 7477907
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anatomical and affinity state comparisons between dopamine D1 and D2 receptors in the rat central nervous system.
    Richfield EK; Penney JB; Young AB
    Neuroscience; 1989; 30(3):767-77. PubMed ID: 2528080
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dopamine D1 receptor availability is related to social behavior: a positron emission tomography study.
    Plavén-Sigray P; Gustavsson P; Farde L; Borg J; Stenkrona P; Nyberg L; Bäckman L; Cervenka S
    Neuroimage; 2014 Nov; 102 Pt 2():590-5. PubMed ID: 25134976
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multicompartmental analysis of [11C]-carfentanil binding to opiate receptors in humans measured by positron emission tomography.
    Frost JJ; Douglass KH; Mayberg HS; Dannals RF; Links JM; Wilson AA; Ravert HT; Crozier WC; Wagner HN
    J Cereb Blood Flow Metab; 1989 Jun; 9(3):398-409. PubMed ID: 2541148
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selective up-regulation of D-1 dopamine receptors following chronic administration of SCH 39166 in primates.
    Duffy RA; Kaminska G; Chipkin RE; McQuade RD
    Pharmacol Biochem Behav; 1992 Jan; 41(1):235-8. PubMed ID: 1531704
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PET study of the effects of valproate on dopamine D(2) receptors in neuroleptic- and mood-stabilizer-naive patients with nonpsychotic mania.
    Yatham LN; Liddle PF; Lam RW; Shiah IS; Lane C; Stoessl AJ; Sossi V; Ruth TJ
    Am J Psychiatry; 2002 Oct; 159(10):1718-23. PubMed ID: 12359678
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Age-related reduction in dopamine D1 receptors in the human brain: from late childhood to adulthood, a positron emission tomography study.
    Jucaite A; Forssberg H; Karlsson P; Halldin C; Farde L
    Neuroscience; 2010 Apr; 167(1):104-10. PubMed ID: 20109534
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reduction of [3H]nicotine binding in hypothalamic and cortical membranes by dopamine D1 receptors.
    Fuxe K; von Euler G; Finnman UB; Agnati LF
    Acta Physiol Scand; 1989 Jun; 136(2):295-6. PubMed ID: 2528887
    [No Abstract]   [Full Text] [Related]  

  • 58. Positron emission tomographic analysis of central dopamine D1 receptor binding in normal subjects treated with the atypical neuroleptic, SDZ MAR 327.
    Christian BT; Babich JW; Livni E; Alpert NM; Bonab AA; Munconi L; Polinski R; Rubin RH; Fischman AJ
    Int J Mol Med; 1998 Jan; 1(1):243-7. PubMed ID: 9852226
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dopamine D1-receptor binding in the living human brain.
    Sedvall G; Farde L; Stone-Elander S; Halldin C
    Adv Exp Med Biol; 1986; 204():119-24. PubMed ID: 2947423
    [No Abstract]   [Full Text] [Related]  

  • 60. Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in bipolar depression.
    Bauer M; London ED; Rasgon N; Berman SM; Frye MA; Altshuler LL; Mandelkern MA; Bramen J; Voytek B; Woods R; Mazziotta JC; Whybrow PC
    Mol Psychiatry; 2005 May; 10(5):456-69. PubMed ID: 15724143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.